Novolog vs. Fiasp Insulin in Non-critically Ill Hospitalized Patients With Type 2 Diabetes Mellitus
Clinical trial NCT04460326 · COMPLETED
Trial details
- NCT number
- NCT04460326
- Sponsor
- Boston Medical Center
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-07
- Primary completion
- 2023-05-27
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.